Role of nanocarriers for inflammation treatment

No Thumbnail Available
File version
Author(s)
Sharma, Akshansh
Sharma, Ishan
Ankit
Singh, Sachin Kumar
Dua, Kamal
Pandey, Sadanand
Kumar, Deepak
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)

Singh, Ravindra Pratap

Singh, Kshitij RB

Singh, Jay

Adetunji, Charles Oluwaseun

Date
2023
Size
File type(s)
Location
License
Abstract

Nanotechnology plays a vital role in medication delivery, and different types of nanoparticles (NPs) have shown unique features that might lead to new therapeutic treatment options. Anti-inflammatory medicines have exploited NP-mediated drug delivery methods. Inflammation’s pathophysiology has a large influence on disorder like as bone, skin, and internal. Anti-inflammatory medication distribution that is efficient can minimize medical dose while also improving therapeutic impact. In this chapter, we examine NPs with possible anti-inflammatory efficacy, as well as a future outlook on nanomedicine’s applicability in inflammatory illnesses.

Journal Title
Conference Title
Book Title

Nanotechnology for Drug Delivery and Pharmaceuticals

Edition
Volume
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Persistent link to this record
Citation

Sharma, A; Sharma, I; Ankit; Singh, SK; Dua, K; Pandey, S; Kumar, D, Role of nanocarriers for inflammation treatment, Nanotechnology for Drug Delivery and Pharmaceuticals, 2023, pp. 111-129

Collections